Agency theory, drug formularies, and drug product selection: Implications for public policy

Journal of Public Policy and Marketing

Volumn 17, Issue 2, 1998, Pages 287-295

  Mott, David A ^a   Schommer, Jon C ^b   Doucette, William R ^c   Kreling, David H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032269418     PISSN: 07439156     EISSN: 15477207     Source Type: Journal    
DOI: 10.1177/074391569801700211     Document Type: Article

References (44)

1. Arrow, Kenneth J. (1963), "Uncertainty and the Welfare Economics of Medical Care," American Economic Review, 53 (5), 941-73.
2. _ (1974), Essays on the Theory of Risk Bearing. Amsterdam: North Holland Publishing Company.
3. _ (1985), "The Economics of Agency," in Principals and Agents: The Structure of Business, John W. Pratt and Richard J. Zeckhauser, eds. Boston, MA: Harvard Business School Press, 37-51.
4. Avorn, Jerry and Stephen B. Soumerai (1983), "Improving DrugTherapy Decisions Through Educational Outreach: A Randomized Controlled Trial of Academically Based 'Detailing'," New England Journal of Medicine, 308 (24), 1457-63.
5. Bergen, Mark, Shantanu Dutta, and Orville C. Walker Jr. (1992), "Agency Relationships in Marketing: A Review of the Implications and Applications of Agency and Related Theories," Journal of Marketing, 56 (July), 1-24.
6. Blomqvist, Ake (1991), "The Doctor as Double Agent: Information Asymmetry, Health Insurance, and Medical Care," Journal of Health Economics. 10 (4), 411-32.
7. CibaGeneva Pharmaceuticals (1996), CibaGeneva Pharmacy Benefit Report: 1996 Trends and Forecasts. Summit, NJ: CibaGeigy Corporation.
8. Cuffel, Brian J., Lonnie Snowden, Mary Masland, and Giorgio Piccagli (1996), "Managed Care in the Public Mental Health System," Community Mental Health Journal, 32 (2), 109-24.
9. Davis, Karen, Karen Scott Collins, Cathy Shoen, and Cynthia Morris (1995), "Choice Matters: Enrollees' Views of their Health Plans," Health Affairs, 14 (Summer), 99-112.
10. Department of Health and Human Services Office of the Inspector General (1997), Experiences of Health Maintenance Organizations with Pharmacy Benefit Management Companies. Washington, DC: DHHS OIG (April).
11. Dranove, David and William D. White (1987), "Agency and the Organization of Health Care Delivery," Inquiry, 24 (Winter), 405-15.
12. Eddy, David M. (1984), "Variations in Physician Practice: The Role of Uncertainty," Health Affairs, 3 (Summer), 74-89.
13. Eisenberg, John M. (1985), "Physician Utilization: The State of Research About Physicians' Practice Patterns," Medical Care, 23 (5), 461-83.
14. Eisenhardt, Kathleen M. (1985), "Control: Organizational and Economic Approaches," Management Science, 31 (2), 134-49.
15. _ (1989), "Agency Theory: An Assessment and Review," Academy of Management Review, 14 (1), 57-74.
16. Feldstein, Martin S. (1981), Hospital Costs and Health Insurance. Cambridge, MA: Harvard University Press.
17. Frey, B.S. (1993), "Does Monitoring Increase Work Effort?" Economic Inquiry, 31 (4), 663-70.
18. General Accounting Office (1996), Medicaid States' Efforts to Educate and Enroll Beneficiaries in Managed Care. Washington, DC: GAO/HEHS-96-184.
19. _ (1997), Medicare HCFA Should Release Data to Aid Consumers, Prompt Better HMO Performance. Washington, DC: GAO/HEHS -97-23.
20. Goldberg, Robert B. (1997), "Managing the Pharmacy Benefit: The Formulary System," Journal of Managed Care Pharmacy, 3 (5), 565-73.
21. Gooding, Sandra S., Darlene B. Smith, and Mark Peyrot (1996), "Insurance Coverage and the Appropriate Utilization of Emergency Departments," Journal of Public Policy & Marketing, 15 (1), 76-86.
22. Hemminki, Elina (1975), "Review of Literature on the Factors Affecting Drug Prescribing," Social Science and Medicine, 9 (2), 111-15.
23. Hibbard, Judith H. and Jacquelyn J. Jewitt (1997), "Will Quality Report Cards Help Consumers?" Health Affairs, 16 (3), 218-28.
24. Jensen, Michael C. and William H. Meckling (1976), "Theory of the Firm: Managerial Behavior, Agency Costs and Ownership Structure," Journal of Financial Economics, 3 (4), 305-60.
25. Johnson, Jeffrey A. and Lyle Bootman (1995), "Drug-Related Morbidity and Mortality: A Cost-of-Illness Model," Archives of Internal Medicine, 155 (18), 1949-56.
26. Kaiser Commission on the Future of Medicaid (1995), Medicaid and Managed Care. Washington, DC: Kaiser Commission on the Future of Medicaid.
27. Mechanic, David (1996), "Changing Medical Organization and the Erosion of Trust," Milbank Quarterly, 74 (2), 171-89.
28. Muirhead, Greg (1997), "Room to Grow: Is Medicaid the Last Holdout for PBMs?" Drug Topics, 141 (July 7), 58.
29. Pathak, Dev S. (1983), "Introduction to Pharmaceutical Marketing," in Principles of Pharmaceutical Marketing, Mickey C. Smith, ed. Philadelphia, PA: Lea and Febiger, 5-24.
30. Pauly, Mark V. (1980), Doctors and Their Workshops. Chicago: University of Chicago Press.
31. Pineault, Reynauld (1977), "The Effect of Medical Training Factors on Physician Utilization Behavior," Medical Care, 15 (1), 51-67.
32. Pontes, Manuel C. (1995), "Agency Theory: A Framework for Analyzing Physicians Services," Health Care Management Review, 20 (4), 57-67.
33. Pratt, John W. (1964), "Risk Aversion in the Small and the Large Firm," Econometrica, 32 (12), 122-36.
34. _ and Richard J. Zeckhauser (1985), "Principals and Agents: An Overview," in Principals and Agents: The Structure of Business, John W. Pratt and Richard J. Zeckhauser, eds. Boston, MA: Harvard Business School Press, 1-35.
35. Raman, Pushkala and Kartik Pashupati (1995), "His Masters' Voices: The Single Agent-Dual Principal Problem in Service Encounters," in Marketing Theory and Applications: AMA Winter Educator Conference, David W. Stewart and Naufel J. Vilcassim, eds. Chicago: American Marketing Association, 162-67.
36. Schondelmeyer, Stephen W. and Enrique Seoane-Vazquez (1996), "1996 Survey: Prescription Trends," American Druggist, 213 (June), 24-29, 40.
37. Schwartz, Rebecca K., Stephen B. Soumerai, and Jerry Avorn (1989), "Physician Motivations for Nonscientific Drug Prescribing," Social Science and Medicine, 28 (6), 577-82.
38. Sharma, Anurag (1997), "Professional as Agent: Knowledge Asymmetry in Agency Exchange," Academy of Management Review, 22 (3), 758-98.
39. Siegelman, S. (1971), "Total RX Volume Hits 4 Billion Dollars: Third Party Prescriptions Zoom 27.5% in 1970," American Druggist, 166 (April 5), 22-23.
40. Soumerai, Stephen B., Dennis Ross-Degnan, Eric E. Fortess, and Julia Abelson (1993), "A Critical Analysis of State Drug Reimbursement Policies: Research in Need of Discipline," Milbank Quarterly, 71 (2), 217-52.
41. Turner, Paul D. and Luis G. Pol (1995), "Beyond Patient Satisfaction" Journal of Health Care Marketing, 15 (3), 45-53.
42. Varner, Theresa and Jack Christy (1986), "Consumer Information Needs in a Competitive Health Care Environment," Health Care Financing Review, 6 (Supplement), 99-104.
43. Welch, W. Pete (1996), "Growth in HMO Share of the Medicare Market, 1989-1994," Health Affairs, 15 (3), 201-14.
44. Woodwell, David A. (1997), National Ambulatory Medical Care Survey: 1995 Summary, No. 286. Washington, DC: Advance Data from Vital and Health Statistics, National Center for Health Statistics.